Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Shwetha H. Manjunath"'
Autor:
Jonathan Baron, Christopher M. Wright, Daniel Y. Lee, Maribel Carpenter, Shwetha H. Manjunath, César A. Briceño, Elise Chong, Amit Maity, John P. Plastaras, Ima Paydar
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeRadiation therapy (RT) with doses ranging from 24 Gray (Gy) to 40 Gy is a proven treatment modality for indolent orbital adnexal lymphoma (IOAL), but recently the use of low dose RT (LDRT, defined as 2 Gy x 2 fractions) has become a notable al
Externí odkaz:
https://doaj.org/article/9ee59b7752484a129ada7e416a91094f
Autor:
Graeme R. Williams, MD, MBA, Anish A. Butala, MD, Shwetha H. Manjunath, MD, Russell J.L. Maxwell, MD, Emily J. Anstadt, MD, PhD, Adam J. Waxman, MD, Joshua A. Jones, MD, John P. Plastaras, MD, PhD, Ima Paydar, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100720- (2021)
Purpose: Myeloma lesions of the head can present with central nervous system (CNS) involvement (leptomeningeal disease or brain metastasis), cranial neuropathy (CN), or impending neurologic involvement (INI). We analyzed response and survival after p
Externí odkaz:
https://doaj.org/article/e2e2bbcdfa2441f48a165074dbc85826
Autor:
Ima Paydar, Michael C. Milone, Carl H. June, Bruce L. Levine, Edward A. Stadtmauer, John P. Plastaras, Joshua A. Jones, Amit Maity, W. Tristram Arscott, Russell Maxwell, J. Joseph Melenhorst, Alfred L. Garfall, Megan M. Davis, Simon F. Lacey, Adam D. Cohen, Shwetha H. Manjunath
sTable 1 shows radiation characteristics of Group A, B, and C. sTable 2 shows characteristics of CART-BCMA cells during manufacturing and at peak expansion in vivo in Group A, B, and C. sTable 3 shows details of radiation received after CART-BCMA the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46061aff28cdcaba2e043092128a5cf5
https://doi.org/10.1158/1078-0432.22483659
https://doi.org/10.1158/1078-0432.22483659
Autor:
Ima Paydar, Michael C. Milone, Carl H. June, Bruce L. Levine, Edward A. Stadtmauer, John P. Plastaras, Joshua A. Jones, Amit Maity, W. Tristram Arscott, Russell Maxwell, J. Joseph Melenhorst, Alfred L. Garfall, Megan M. Davis, Simon F. Lacey, Adam D. Cohen, Shwetha H. Manjunath
Purpose:B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor (CAR) T cells (CART-BCMA) are a promising treatment for relapsed/refractory multiple myeloma (r/rMM). We evaluated the safety and feasibility of bridging radiation (RT) in su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8224430051dfc4a0f53c6c9c9b86cb
https://doi.org/10.1158/1078-0432.c.6531195.v1
https://doi.org/10.1158/1078-0432.c.6531195.v1
Publikováno v:
Surgical Oncology Clinics of North America. 30:563-580
Palliative radiotherapy (PRT) is well-tolerated, effective treatment for pain, bleeding, obstruction, and other symptoms/complications of advanced cancer. It is an important component of multidisciplinary management. It should be considered even for
Autor:
Shannon R. McCurdy, Jacob A Radcliff, Danielle A. Cenin, Noelle V. Frey, Daria V. Babushok, Mary Ellen Martin, Elizabeth O. Hexner, Shwetha H. Manjunath, Alexander E. Perl, Mitchell E. Hughes, Saar Gill, John P. Plastaras, Edward A. Stadtmauer, Craig W. Freyer, Keith W. Pratz, Amit Maity, David L. Porter, Selina M. Luger, Alison W. Loren, Alison Carulli, Colleen Timlin
Publikováno v:
Transplantation and Cellular Therapy. 27:S455-S457
Publikováno v:
Surgical oncology clinics of North America. 30(3)
Palliative radiotherapy (PRT) is well-tolerated, effective treatment for pain, bleeding, obstruction, and other symptoms/complications of advanced cancer. It is an important component of multidisciplinary management. It should be considered even for
Autor:
Joshua Jones, Graeme R. Williams, Shwetha H. Manjunath, Emily J. Anstadt, Adam Waxman, Anish A. Butala, John P. Plastaras, R.J.L. Maxwell, Ima Paydar
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100720-(2021)
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100720-(2021)
Purpose: Myeloma lesions of the head can present with central nervous system (CNS) involvement (leptomeningeal disease or brain metastasis), cranial neuropathy (CN), or impending neurologic involvement (INI). We analyzed response and survival after p
Autor:
Craig A. Portell, Meredith I. Larose, Stephen J. Schuster, Tatyana Feldman, John P. Plastaras, Daniel J. Landsburg, James N. Gerson, Sayan Mullick Chowdhury, Jordan Carter, Elise A. Chong, Stefan K. Barta, Ima Paydar, Leidy Isenalumhe, Steven M. Bair, Jordan Intrator, Sunita D. Nasta, Jakub Svoboda, Andrew M. Evens, Krista Isaac, Shwetha H. Manjunath, Hayder Saeed, Narendranath Epperla
Publikováno v:
Blood. 136:31-32
Background: Current standard of care for most patients (pts) with relapsed/refractory (RR) classical Hodgkin lymphoma (cHL) is systemic salvage chemotherapy followed by autologous stem cell transplant (ASCT). Given the treatment-related toxicities as
Autor:
Anish A. Butala, John P. Plastaras, Joshua Jones, Adam Waxman, Ima Paydar, Graeme R. Williams, Shwetha H. Manjunath
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:E59